Press/Media

Six Questions Benefit Providers Should Ask Their PGx Partner
November 24, 2021

Click here to read "Six Questions Benefit Providers Should Ask Their PGx Partner"

Read more
Inagene Diagnostics Inc.’s CEO featured alongside global expert advocates highlighting pharmacogenomic (gene-drug compatibility) testing as a game-changing innovation to safeguard the health of Canadians
November 09, 2021

Click here to read the article on the GlobeNewswire website

Read more
Inagene Diagnostics Inc. and Granville Biomedical Inc. team up to provide locally-produced pharmacogenetic testing kits to Canadians
November 09, 2021

Click here to read the article on the GlobeNewswire website

Read more
Pharmacogenetic testing uses DNA to predict patients’ responses to medications
November 09, 2021

Click here to read the article on the Globe and Mail website

Read more
September's International Pain Awareness Month marks critical moment to leverage more effective methods of treating chronic pain…
November 09, 2021

Click here to read the article on the Financial Post website

Read more
Canada's surgery backlog could lead to wave of new chronic pain and opioid dependencies According to Inagene Diagnostics Inc., genetic testing can help mitigate the risk of chronic pain and reliance on medications
November 09, 2021

Click here to read the article on the Financial Post website

Read more
Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing…
November 09, 2021

Click here to read the article on the Financial Post website

Read more
Inagene Pharmacogenetic Testing Featured on Global News
November 08, 2021

Click here to watch the Global News segment featuring Inagene Pharmacogenetic Testing

Read more